Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
5
×
new york top stories
novartis
5
×
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
celgene
deals
fda
ipo
startups
takeda pharmaceutical
abbvie
alexion pharmaceuticals
allergan
What
bio
roundup
days
drug
drugs
pharmaceutical
price
typically
acquisitions
airport
alzheimer’s
annual
apocalypse
august
bails
beds
biggest
biotech
brand
bridgebio
build
busy
buy
capital
car
celgene
ceo
companies
company’s
daniel
debut
decisions
develop
devices
different
dyne’s
emerges
fail
fallout
fda
Language
unset
Current search:
novartis
×
pfizer
×
" new york blog main "
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
